Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
LSL Pharma Group Inc ( (TSE:LSL) ) just unveiled an announcement.
LSL Pharma Group Inc. has announced the early redemption and cancellation of all its 11% Unsecured Convertible Debentures, originally set to mature in 2028. This financial move, which involved a total payout of over $3.5 million to debenture holders, led to the delisting of these debentures from the TSX Venture Exchange, potentially strengthening the company’s financial position and market perception.
More about LSL Pharma Group Inc
LSL Pharma Group Inc. is a Canadian integrated pharmaceutical company that specializes in the development, manufacturing, and commercialization of high-quality sterile ophthalmic pharmaceutical products, as well as pharmaceutical, cosmetic, and natural health products in various dosage forms. The group includes companies such as Steri-Med Pharma Inc., LSL Laboratory Inc., Virage Santé Inc., and Dermolab Pharma Ltd.
Average Trading Volume: 45,864
Technical Sentiment Signal: Sell
Find detailed analytics on LSL stock on TipRanks’ Stock Analysis page.